Leading global health care company
This client was deeply concerned that their self-described highly risk adverse culture was limiting innovation, yet wanted to spur innovation within that constraint. We conducted a set of Netstorms™ and associated working sessions to develop a strategy for directed innovation where the risk was largely outsourced to the Network. We used these sessions to examine and revisit key issues associated with determining if and when a product was ready to go to market and how to drive innovation in marketing and go-to-market and not just in the product itself. In addition, we helped them understand how to innovate at the business planning stage, versus only at the product level.